Advertisement

Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update

Published:January 30, 2019DOI:https://doi.org/10.1016/j.radonc.2019.01.018

      Highlights

      • Updated proposal for the selection of nodal target volumes in definitive radiotherapy is provided.
      • Recommendations for both negative and positive neck are provided.
      • The locations addressed are: oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity and carcinoma of unknown primary.
      • Recommendations are according to the latest neck node level terminology and staging.

      Abstract

      Background and purpose

      In 2000, a panel of experts published a proposal for the selection of lymph node target volumes for definitive head and neck radiation therapy (Radiother Oncol, 2000; 56: 135–150). Hereunder, this selection is updated and extended to also cover primary sites not previously covered.

      Patients and methods

      The lymphatic spread of head and neck cancers into neck lymph nodes was comprehensively reviewed based on radiological, surgical and pathological literature regarding both initial involvement and patterns of failure. Then a panel of worldwide head and neck radiotherapy experts agreed on a consensus for the selection of both high- and low-risk lymph node target volumes for the node negative and the node positive neck.

      Results

      An updated selection of lymph node target volumes is reported for oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity and carcinoma of unknown primary as a function of the nodal staging (UICC 8th edition).

      Conclusions

      The selection of lymph node target volumes for head and neck cancers treated with IMRT/VMAT or other highly conformal techniques (e.g. proton therapy) requires a rigorous approach. This updated proposal of selection should help clinicians for the selection of lymph nodes target volumes and contribute to increase consistency.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Toledano I.
        • Graff P.
        • Serre A.
        • Boisselier P.
        • Bensadoun R.-J.
        • Ortholan C.
        • et al.
        Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004–03.
        Radiother Oncol. 2012; 103: 57-62
        • Nutting C.M.
        • Morden J.P.
        • Harrington K.J.
        • Urbano T.G.
        • Bhide S.A.
        • Clark C.
        • et al.
        Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
        Lancet Oncol. 2011; 12: 127-136
        • Rathod S.
        • Gupta T.
        • Ghosh-Laskar S.
        • Murthy V.
        • Budrukkar A.
        • Agarwal J.
        Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
        Oral Oncol. 2013; 49: 634-642
        • Gupta T.
        • Agarwal J.
        • Jain S.
        • Phurailatpam R.
        • Kannan S.
        • Ghosh-Laskar S.
        • et al.
        Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
        Radiother Oncol. 2012; 104: 343-348
        • Kam M.K.M.
        • Leung S.-F.
        • Zee B.
        • Chau R.M.C.
        • Suen J.J.S.
        • Mo F.
        • et al.
        Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
        J Clin Oncol. 2007; 25: 4873-4879
        • Lindberg R.
        Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts.
        Cancer. 1972; 29: 1446-1449
        • Mukherji S.K.
        • Armao D.
        • Joshi V.M.
        Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect.
        Head Neck. 2001; 23: 995-1005
        • Byers R.M.
        • Weber R.S.
        • Andrews T.
        • McGill D.
        • Kare R.
        • Wolf P.
        Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue.
        Head Neck. 1997; 19: 14-19
        • Woolgar J.A.
        Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas.
        Br J Oral Maxillofac Surg. 1999; 37: 175-180
        • Candela F.C.
        • Kothari K.
        • Shah J.P.
        Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx.
        Head Neck. 1990; 12: 197-203
        • Lapeyre M.
        • Miroir J.
        • Biau J.
        Delineation of the lymph nodes for head neck cancers.
        Cancer Radiother. 2014; 18: 572-576
        • Grégoire V.
        • Coche E.
        • Cosnard G.
        • Hamoir M.
        • Reychler H.
        Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.
        Radiother Oncol. 2000; 56: 135-150
        • Grégoire V.
        • Levendag P.
        • Ang K.K.
        • Bernier J.
        • Braaksma M.
        • Budach V.
        • et al.
        CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines.
        Radiother Oncol. 2003; 69: 227-236
        • Chao K.S.C.
        • Wippold F.J.
        • Ozyigit G.
        • Tran B.N.
        • Dempsey J.F.
        Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.
        Int J Radiat Oncol Biol Phys. 2002; 53: 1174-1184
        • Vorwerk H.
        • Hess C.F.
        Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region.
        Radiat Oncol. 2011; 6: 97
        • Eisbruch A.
        • Foote R.L.
        • O’Sullivan B.
        • Beitler J.J.
        • Vikram B.
        Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.
        Semin Radiat Oncol. 2002; 12: 238-249
        • Grégoire V.
        • Eisbruch A.
        • Hamoir M.
        • Levendag P.
        Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck.
        Radiother Oncol. 2006; 79: 15-20
        • Grégoire V.
        • Ang K.
        • Budach W.
        • Grau C.
        • Hamoir M.
        • Langendijk J.A.
        • et al.
        Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
        Radiother Oncol. 2014; 110: 172-181
        • Amin M.B.
        • Greene F.L.
        • Edge S.B.
        • Compton C.C.
        • Gershenwald J.E.
        • Brookland R.K.
        • et al.
        The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging.
        CA Cancer J Clin. 2017; 67: 93-99
        • Brierley J.D.
        • Gospodarowicz M.K.
        • Wittekind C.
        TNM classification of malignant tumours.
        8th ed. Wiley, 2018
        • Schinagl D.A.X.
        • Hoffmann A.L.
        • Vogel W.V.
        • van Dalen J.A.
        • Verstappen S.M.M.
        • Oyen W.J.G.
        • et al.
        Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?.
        Radiother Oncol. 2009; 91: 95-100
        • Grégoire V.
        • Jeraj R.
        • Lee J.A.
        • O’Sullivan B.
        Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?.
        Lancet Oncol. 2012; 13: e292-e300
        • Fried D.
        • Lawrence M.
        • Khandani A.H.
        • Rosenman J.
        • Cullip T.
        • Chera B.S.
        Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?.
        Int J Radiat Oncol Biol Phys. 2012; 84: 748-754
        • Delouya G.
        • Igidbashian L.
        • Houle A.
        • Bélair M.
        • Boucher L.
        • Cohade C.
        • et al.
        18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
        Radiother Oncol. 2011; 101: 362-368
        • Mack M.G.
        • Rieger J.
        • Baghi M.
        • Bisdas S.
        • Vogl T.J.
        Cervical lymph nodes.
        Eur J Radiol. 2008; 66: 493-500
        • Nakamura T.
        • Sumi M.
        Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes.
        Eur Radiol. 2007; 17: 1235-1241
        • Thiagarajan A.
        • Caria N.
        • Schöder H.
        • Iyer N.G.
        • Wolden S.
        • Wong R.J.
        • et al.
        Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.
        Int J Radiat Oncol Biol Phys. 2012; 83: 220-227
        • Payabvash S.
        • Meric K.
        • Cayci Z.
        Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging.
        Clin Imaging. 2016; 40: 101-105
        • Hoang J.K.
        • Vanka J.
        • Ludwig B.J.
        • Glastonbury C.M.
        Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach.
        AJR Am J Roentgenol. 2013; 200: W17-W25
        • van den Brekel M.W.
        • Stel H.V.
        • Castelijns J.A.
        • Nauta J.J.
        • van der Waal I.
        • Valk J.
        • et al.
        Cervical lymph node metastasis: assessment of radiologic criteria.
        Radiology. 1990; 177: 379-384
        • van den Bosch S.
        • Dijkema T.
        • Verhoef L.C.G.
        • Zwijnenburg E.M.
        • Janssens G.O.
        • Kaanders J.H.A.M.
        Patterns of recurrence in electively irradiated lymph node regions after definitive accelerated intensity modulated radiation therapy for head and neck squamous cell carcinoma.
        Int J Radiat Oncol Biol Phys. 2016; 94: 766-774
        • Rohde M.
        • Dyrvig A.-K.
        • Johansen J.
        • Sørensen J.A.
        • Gerke O.
        • Nielsen A.L.
        • et al.
        18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
        Eur J Cancer. 2014; 50: 2271-2279
        • Kyzas P.A.
        • Evangelou E.
        • Denaxa-Kyza D.
        • Ioannidis J.P.A.
        18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
        J Natl Cancer Inst. 2008; 100: 712-720
        • Behr-Ventura D.
        • Kendi A.K.
        • Brandon D.
        Which way do I go? Gaining an understanding of head and neck lymphatic drainage patterns.
        J Nucl Med. 2014; 55 (1366 1366)
        • Al-Mamgani A.
        • Verheij M.
        • van den Brekel M.W.M.
        Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: a paradigm shift.
        Eur J Cancer. 2017; 82: 1-5
        • Merlotti A.
        • Alterio D.
        • Vigna-Taglianti R.
        • Muraglia A.
        • Lastrucci L.
        • Manzo R.
        • et al.
        Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology – head and neck working group.
        Radiat Oncol. 2014; 9: 264
        • Vergeer M.R.
        • Doornaert P.A.H.
        • Jonkman A.
        • Kaanders J.H.A.M.
        • van den Ende P.L.A.
        • de Jong M.A.
        • et al.
        Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
        Int J Radiat Oncol Biol Phys. 2010; 78: 682-688
        • Hong T.S.
        • Tomé W.A.
        • Harari P.M.
        Heterogeneity in head and neck IMRT target design and clinical practice.
        Radiother Oncol. 2012; 103: 92-98
        • van den Bosch S.
        • Vogel W.V.
        • Raaijmakers C.P.
        • Dijkema T.
        • Terhaard C.H.J.
        • Al-Mamgani A.
        • et al.
        Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
        Radiother Oncol. 2018; 128: 472-478
        • Robbins K.T.
        Classification of neck dissection: current concepts and future considerations.
        Otolaryngol Clin North Am. 1998; 31: 639-655
        • Ferlito A.
        • Silver C.E.
        • Rinaldo A.
        Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies.
        Br J Oral Maxillofac Surg. 2009; 47: 5-9
        • González-García R.
        • Naval-Gías L.
        • Sastre-Pérez J.
        • Rodríguez-Campo F.J.
        • Muñoz-Guerra M.F.
        • Usandizaga J.L.G.-D.
        • et al.
        Contralateral lymph neck node metastasis of primary squamous cell carcinoma of the tongue: a retrospective analytic study of 203 patients.
        Int J Oral Maxillofac Surg. 2007; 36: 507-513
        • Ganly I.
        • Goldstein D.
        • Carlson D.L.
        • Patel S.G.
        • O’Sullivan B.
        • Lee N.
        • et al.
        Long-term regional control and survival in patients with “low-risk”, early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness.
        Cancer. 2013; 119: 1168-1176
      1. Koo BS, Lim YC, Lee JS, Choi EC. Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck. 28:896–901.

        • Kjems J.
        • Gothelf A.B.
        • Håkansson K.
        • Specht L.
        • Kristensen C.A.
        • Friborg J.
        Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy.
        Int J Radiat Oncol Biol Phys. 2016; 94: 775-782
        • Kim Y.
        • Cho K.H.
        • Moon S.H.
        • Lee C.G.
        • Keum K.C.
        • Lee S.-W.
        • et al.
        Comparison of the clinical outcomes of patients with squamous cell carcinoma of the tonsil receiving postoperative ipsilateral versus bilateral neck radiotherapy: a propensity score matching analysis (KROG 11–07).
        Cancer Res Treat. 2017; 49: 1097-1105
        • Al-Mamgani A.
        • van Werkhoven E.
        • Navran A.
        • Karakullukcu B.
        • Hamming-Vrieze O.
        • Machiels M.
        • et al.
        Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: a literature-based critical review.
        Cancer Treat Rev. 2017; 59: 102-108
        • Hu K.S.
        • Mourad W.F.
        • Gamez M.
        • Safdieh J.
        • Lin W.
        • Jacobson A.S.
        • et al.
        Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization.
        Head Neck. 2017; 39: 1647-1654
        • Huang S.H.
        • Waldron J.
        • Bratman S.V.
        • Su J.
        • Kim J.
        • Bayley A.
        • et al.
        Re-evaluation of ipsilateral radiation for T1–T2N0-N2b tonsil carcinoma at the princess Margaret hospital in the human papillomavirus era, 25 years later.
        Int J Radiat Oncol Biol Phys. 2017; 98: 159-169
        • Rackley T.P.
        • Namelo W.C.
        • Palaniappan N.
        • Cole N.
        • Owens D.M.J.
        • Evans M.
        Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
        Head Neck. 2017; 39: 17-23
        • O’Sullivan B.
        • Warde P.
        • Grice B.
        • Goh C.
        • Payne D.
        • Liu F.F.
        • et al.
        The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region.
        Int J Radiat Oncol Biol Phys. 2001; 51: 332-343
        • Shah J.P.
        Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract.
        Am J Surg. 1990; 160: 405-409
        • de Bree R.
        • Leemans C.R.
        • Silver C.E.
        • Robbins K.T.
        • Rodrigo J.P.
        • Rinaldo A.
        • et al.
        Paratracheal lymph node dissection in cancer of the larynx, hypopharynx, and cervical esophagus: the need for guidelines.
        Head Neck. 2011; 33: 912-916
        • Koo B.S.
        • Lim Y.C.
        • Lee J.S.
        • Kim Y.-H.
        • Kim S.-H.
        • Choi E.C.
        Management of contralateral N0 neck in pyriform sinus carcinoma.
        Laryngoscope. 2006; 116: 1268-1272
        • Chung E.-J.
        • Kim G.-W.
        • Cho B.-K.
        • Park H.S.
        • Rho Y.-S.
        Pattern of lymph node metastasis in hypopharyngeal squamous cell carcinoma and indications for level VI lymph node dissection.
        Head Neck. 2016; 38: E1969-E1973
        • Joo Y.-H.
        • Sun D.-I.
        • Cho K.-J.
        • Cho J.-H.
        • Kim M.-S.
        The impact of paratracheal lymph node metastasis in squamous cell carcinoma of the hypopharynx.
        Eur Arch Oto-Rhino-Laryngol. 2010; 267: 945-950
        • Wu Z.
        • Deng X.-Y.
        • Zeng R.-F.
        • Su Y.
        • Gu M.-F.
        • Zhang Y.
        • et al.
        Analysis of risk factors for retropharyngeal lymph node metastasis in carcinoma of the hypopharynx.
        Head Neck. 2013; 35: 1274-1277
        • Zumsteg Z.S.
        • Riaz N.
        • Jaffery S.
        • Hu M.
        • Gelblum D.
        • Zhou Y.
        • et al.
        Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1–2N0 laryngeal carcinoma.
        Oral Oncol. 2015; 51: 716-723
        • Khan M.K.
        • Koyfman S.A.
        • Hunter G.K.
        • Reddy C.A.
        • Saxton J.P.
        Definitive radiotherapy for early (T1–T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
        Radiat Oncol. 2012; 7: 193
        • Stokes W.A.
        • Abbott D.
        • Phan A.
        • Raben D.
        • Lanning R.M.
        • Karam S.D.
        Patterns of care for patients with early-stage glottic cancer undergoing definitive radiation therapy: a national cancer database analysis.
        Int J Radiat Oncol Biol Phys. 2017; 98: 1014-1021
        • Rock K.
        • Huang S.H.
        • Tiong A.
        • Lu L.
        • Xu W.
        • Ringash J.
        • et al.
        Partial laryngeal IMRT for T2N0 glottic cancer: impact of image guidance and radiation therapy intensification.
        Int J Radiat Oncol Biol Phys. 2018; 102: 941-949
        • Dos Santos C.R.
        • Gonçalves Filho J.
        • Magrin J.
        • Johnson L.F.
        • Ferlito A.
        • Kowalski L.P.
        Involvement of level I neck lymph nodes in advanced squamous carcinoma of the larynx.
        Ann Otol Rhinol Laryngol. 2001; 110: 982-984
        • Ma H.
        • Lian M.
        • Feng L.
        • Li P.
        • Hou L.
        • Liu H.
        • et al.
        Management of cervical lymph nodes for cN0 advanced glottic laryngeal carcinoma and its long-term results.
        Acta Otolaryngol (Stockh). 2014; 134: 952-958
        • Weber R.S.
        • Marvel J.
        • Smith P.
        • Hankins P.
        • Wolf P.
        • Goepfert H.
        Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus.
        Otolaryngol-Head Neck Surg. 1993; 108: 11-17
        • Dequanter D.
        • Shahla M.
        • Zouaoui Boudjeltia K.
        • Paulus P.
        • Lothaire P.
        Neck and mediastinal node dissection in pharyngolaryngeal tumors.
        Eur Ann Otorhinolaryngol Head Neck Dis. 2013; 130: 5-7
        • Wang X.
        • Hu C.
        • Ying H.
        • He X.
        • Zhu G.
        • Kong L.
        • et al.
        Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels.
        Radiother Oncol. 2015; 115: 41-45
        • Liu L.-Z.
        • Zhang G.-Y.
        • Xie C.-M.
        • Liu X.-W.
        • Cui C.-Y.
        • Li L.
        Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread.
        Int J Radiat Oncol Biol Phys. 2006; 66: 721-730
        • Lee A.W.
        • Ng W.T.
        • Pan J.J.
        • Poh S.S.
        • Ahn Y.C.
        • AlHussain H.
        • et al.
        International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
        Radiother Oncol. 2018; 126: 25-36
        • Lin L.
        • Lu Y.
        • Wang X.-J.
        • Chen H.
        • Yu S.
        • Tian J.
        • et al.
        Delineation of neck clinical target volume specific to nasopharyngeal carcinoma based on lymph node distribution and the international consensus guidelines.
        Int J Radiat Oncol Biol Phys. 2018; 100: 891-902
        • Robbins K.T.
        • Ferlito A.
        • Silver C.E.
        • Takes R.P.
        • Strojan P.
        • Snyderman C.H.
        • et al.
        Contemporary management of sinonasal cancer.
        Head Neck. 2011; 33: 1352-1365
        • Takes R.P.
        • Ferlito A.
        • Silver C.E.
        • Rinaldo A.
        • Medina J.E.
        • Robbins K.T.
        • et al.
        The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus.
        Eur Arch Oto-Rhino-Laryngol. 2014; 271: 899-904
        • Guan X.
        • Wang X.
        • Liu Y.
        • Hu C.
        • Zhu G.
        Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
        Oral Oncol. 2013; 49: 60-65
        • Cantù G.
        • Bimbi G.
        • Miceli R.
        • Mariani L.
        • Colombo S.
        • Riccio S.
        • et al.
        Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment.
        Arch Otolaryngol Head Neck Surg. 2008; 134: 170-177
        • Ahn P.H.
        • Mitra N.
        • Alonso-Basanta M.
        • Palmer J.N.
        • Adappa N.D.
        • O’Malley B.W.
        • et al.
        Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis.
        Acta Oncol Stockh Swed. 2016; 55: 1107-1114
        • Dubal P.M.
        • Bhojwani A.
        • Patel T.D.
        • Zuckerman O.
        • Baredes S.
        • Liu J.K.
        • et al.
        Squamous cell carcinoma of the maxillary sinus: A population-based analysis.
        Laryngoscope. 2016; 126: 399-404
        • Wiegner E.A.
        • Daly M.E.
        • Murphy J.D.
        • Abelson J.
        • Chapman C.H.
        • Chung M.
        • et al.
        Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure.
        Int J Radiat Oncol Biol Phys. 2012; 83: 243-251
        • Homma A.
        • Hayashi R.
        • Matsuura K.
        • Kato K.
        • Kawabata K.
        • Monden N.
        • et al.
        Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcome.
        Ann Surg Oncol. 2014; 21: 1706-1710
        • Gamez M.E.
        • Lal D.
        • Halyard M.Y.
        • Wong W.W.
        • Vargas C.
        • Ma D.
        • et al.
        Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
        Head Neck. 2017; 39: 1819-1824
        • Kuo P.
        • Manes R.P.
        • Schwam Z.G.
        • Judson B.L.
        Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma.
        Otolaryngol-Head Neck Surg. 2017; 156: 132-136
        • Gangl K.
        • Nemec S.
        • Altorjai G.
        • Pammer J.
        • Grasl M.C.
        • Erovic B.M.
        Prognostic survival value of retropharyngeal lymph node involvement in sinonasal tumors: A retrospective, descriptive, and exploratory study.
        Head Neck. 2017; 39: 1421-1427
        • Bhayani M.K.
        • Yilmaz T.
        • Sweeney A.
        • Calzada G.
        • Roberts D.B.
        • Levine N.B.
        • et al.
        Sinonasal adenocarcinoma: a 16-year experience at a single institution.
        Head Neck. 2014; 36: 1490-1496
        • Scurry W.C.
        • Goldenberg D.
        • Chee M.Y.
        • Lengerich E.J.
        • Liu Y.
        • Fedok F.G.
        Regional recurrence of squamous cell carcinoma of the nasal cavity: a systematic review and meta-analysis.
        Arch Otolaryngol Neck Surg. 2007; 133: 796-800
        • Day T.A.
        • Beas R.A.
        • Schlosser R.J.
        • Woodworth B.A.
        • Barredo J.
        • Sharma A.K.
        • et al.
        Management of paranasal sinus malignancy.
        Curr Treat Options Oncol. 2005; 6: 3-18
        • Unsal A.A.
        • Dubal P.M.
        • Patel T.D.
        • Vazquez A.
        • Baredes S.
        • Liu J.K.
        • et al.
        Squamous cell carcinoma of the nasal cavity: A population-based analysis.
        Laryngoscope. 2016; 126: 560-565
        • Dulguerov P.
        • Allal A.S.
        • Calcaterra T.C.
        Esthesioneuroblastoma: a meta-analysis and review.
        Lancet Oncol. 2001; 2: 683-690
        • Demiroz C.
        • Gutfeld O.
        • Aboziada M.
        • Brown D.
        • Marentette L.J.
        • Eisbruch A.
        Esthesioneuroblastoma: is there a need for elective neck treatment?.
        Int J Radiat Oncol Biol Phys. 2011; 81: e255-e261
        • Peacock J.G.
        • Harmsen W.S.
        • Link M.J.
        • Van Gompel J.J.
        • Giannini C.
        • Olsen K.D.
        • et al.
        Risk of delayed lymph node metastasis in clinically N0 esthesioneuroblastoma.
        J Neurol Surg Part B Skull Base. 2017; 78: 68-74
        • Jiang W.
        • Mohamed A.S.R.
        • Fuller C.D.
        • Kim B.Y.S.
        • Tang C.
        • Gunn G.B.
        • et al.
        The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.
        Pract Radiat Oncol. 2016; 6: 241-247
        • Monroe A.T.
        • Hinerman R.W.
        • Amdur R.J.
        • Morris C.G.
        • Mendenhall W.M.
        Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
        Head Neck. 2003; 25: 529-534
        • Bell D.
        • Saade R.
        • Roberts D.
        • Ow T.J.
        • Kupferman M.
        • DeMonte F.
        • et al.
        Prognostic utility of hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
        Head Neck Pathol. 2014; 9: 51-59
        • García J.
        • López M.
        • López L.
        • Bagué S.
        • Granell E.
        • Quer M.
        • et al.
        Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM Classification of Malignant Tumors.
        Oral Oncol. 2017; 70: 29-33
        • Grau C.
        • Johansen L.V.
        • Jakobsen J.
        • Geertsen P.
        • Andersen E.
        • Jensen B.B.
        Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.
        Radiother Oncol. 2000; 55: 121-129
        • Marcial-Vega V.A.
        • Cardenes H.
        • Perez C.A.
        • Devineni V.R.
        • Simpson J.R.
        • Fredrickson J.M.
        • et al.
        Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries.
        Int J Radiat Oncol Biol Phys. 1990; 19: 919-928
        • Glynne-Jones R.G.
        • Anand A.K.
        • Young T.E.
        • Berry R.J.
        Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy.
        Int J Radiat Oncol Biol Phys. 1990; 18: 289-294
        • Reddy S.P.
        • Marks J.E.
        Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation.
        Int J Radiat Oncol Biol Phys. 1997; 37: 797-802
        • Weir L.
        • Keane T.
        • Cummings B.
        • Goodman P.
        • O’Sullivan B.
        • Payne D.
        • et al.
        Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors.
        Radiother Oncol. 1995; 35: 206-211
        • Perkins S.M.
        • Spencer C.R.
        • Chernock R.D.
        • Haughey B.H.
        • Nussenbaum B.
        • Adkins D.R.
        • et al.
        Radiotherapeutic management of cervical lymph node metastases from an unknown primary site.
        Arch Otolaryngol Head Neck Surg. 2012; 138: 656-661
        • Sinnathamby K.
        • Peters L.J.
        • Laidlaw C.
        • Hughes P.G.
        The occult head and neck primary: to treat or not to treat?.
        Clin Oncol. 1997; 9: 322-329
        • Ghadjar P.
        • Schreiber-Facklam H.
        • Gräter R.
        • Evers C.
        • Simcock M.
        • Geretschläger A.
        • et al.
        Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma.
        Int J Radiat Oncol Biol Phys. 2010; 76: 1127-1132
        • Brannan A.G.
        • Johnstone P.A.S.
        • Cooper J.
        Extracapsular tumor extension in cervical lymph nodes: reconciling the literature and seer data.
        Head Neck. 2011; 33: 525-528
        • Apisarnthanarax S.
        • Elliott D.D.
        • El-Naggar A.K.
        • Asper J.A.
        • Blanco A.
        • Ang K.K.
        • et al.
        Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes.
        Int J Radiat Oncol Biol Phys. 2006; 64: 678-683
        • Salama J.K.
        • Haddad R.I.
        • Kies M.S.
        • Busse P.M.
        • Dong L.
        • Brizel D.M.
        • et al.
        Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
        Int J Radiat Oncol Biol Phys. 2009; 75: 725-733